Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Parasite Immunol ; 41(5): e12620, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30815888

RESUMEN

AIMS: The polymorphism observed in Leishmania braziliensis is associated with different clinical forms of leishmaniasis. Neutrophils (PMNs) participate in the pathogenesis of leishmania infection, and here, we evaluate neutrophil function after infection with isolates of L. braziliensis from cutaneous leishmaniasis (CL) or disseminated leishmaniasis (DL) patients. METHODS AND RESULTS: Neutrophils from 30 healthy subjects (HS) were infected with isolates of L. (V.) braziliensis obtained from three CL and three DL patients. They were infected at the ratio of 3:1 parasites per neutrophil, and leishmania uptake was evaluated by microscopy. The neutrophil activation markers and oxidative burst by expression of dihidrorhodamine (DHR) were evaluated by flow cytometry and cytokine production by ELISA. The frequency of infected cells and the number of amastigotes were higher in neutrophils infected with CL isolates compared to DL isolates (P < 0.05). The DHR and CD66b expression after infection with DL isolate was lower than with CL isolates. There was no difference regarding chemokine production. CONCLUSION: The L. (V.) braziliensis isolates of DL induced lower respiratory burst and neutrophils activation markers compared with CL isolates which may contribute to parasite survival and dissemination in DL patients.


Asunto(s)
Antígenos CD/metabolismo , Moléculas de Adhesión Celular/metabolismo , Leishmania braziliensis/inmunología , Leishmaniasis Cutánea/inmunología , Adolescente , Adulto , Animales , Femenino , Proteínas Ligadas a GPI/metabolismo , Humanos , Leishmania braziliensis/aislamiento & purificación , Leishmaniasis Cutánea/parasitología , Masculino , Activación Neutrófila , Neutrófilos/inmunología , Adulto Joven
2.
Chem Immunol Allergy ; 90: 29-44, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16210901

RESUMEN

Studies have demonstrated that people living in areas endemic for helminths have a decreased reactivity to skin prick tests to aeroallergens and milder forms of asthma. Hypotheses to explain the inverse correlation between helminth infections and atopy include competition between helminth-induced polyclonal IgE and aeroallergen-specific IgE for high-affinity receptors present on mast cells, increased number of regulatory T cells, and high levels of regulatory cytokines, such as IL-10, produced during helminthic infections. Indeed, cells from asthmatic individuals infected with Schistosoma mansoni produce lower levels of IL-5 than asthmatics free of infections. In contrast, IL-10 is more readily produced by allergen-stimulated cells from asthmatics who are infected and is detected only at low levels by cells from helminth-free asthmatics. It is well known that Th2 cytokines are involved in the pathogenesis of allergies and asthma, and some studies indicate that IL-10 is the key cytokine that inhibits the Th2-inflammatory response in allergy. In this chapter we will discuss the association between S. mansoni infection, atopy and severity of asthma and possible mechanisms by which individuals living in helminth endemic areas are protected against the development of allergies.


Asunto(s)
Alérgenos/inmunología , Asma/complicaciones , Asma/inmunología , Schistosoma mansoni/inmunología , Esquistosomiasis/inmunología , Animales , Asma/parasitología , Dermatitis Atópica/inmunología , Dermatitis Atópica/parasitología , Humanos , Modelos Inmunológicos , Esquistosomiasis/complicaciones , Esquistosomiasis/parasitología
3.
Acta Trop ; 93(1): 49-56, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15589797

RESUMEN

The antibody response against Leishmania (Leishmania) amazonensis crude antigen was measured through the indirect immunofluorescent assay (IFA) and the immunoenzymatic assay (ELISA) in 114 patients with cutaneous leishmaniasis (CL) in Brazil. Fifty-four patients were infected by Leishmania (Viannia) braziliensis, and 60 patients had L. (V.) guyanensis infection. Patients were comparable by age, sex, disease duration and the Montenegro skin test diameter. L. (V.) braziliensis-infected patients showed significant lower number of ulcerated lesions, greater ulcerated area and higher proportion of lymph node enlargement. Sensitivity of IFA was 79.6% (95% CI 66.1-88.9) and 71.7% (95% CI 58.4-82.2) for L. (V.) braziliensis and L. (V.) guyanensis-infected patients, respectively (P=0.324). Sensitivity of ELISA was 98.2% (95% CI 88.8-99.9) and 85.0% (95% CI 72.9-92.5) for L. (V.) braziliensis and L. (V.) guyanensis-infected patients, respectively (P=0.018). Significant differences were observed in the magnitude of the antibody response before treatment with higher levels detected in L. (V.) braziliensis-infected patients by both serologic techniques. Eighty-four patients had serologic evaluations before and 12 weeks after treatment with meglumine antimoniate, 20 mg/kg/day for 20 days. Significant lower optic density values were observed after treatment with both species independent of cure or failure. Our data showed that L. (V.) braziliensis induces a higher antibody response against L. (L.) amazonensis antigens than L. (V.) guyanensis and that down-modulation of the antibody response occurs shortly during disease evolution after treatment. Moreover the data support the use of ELISA as a better tool for detection of antibodies in CL.


Asunto(s)
Anticuerpos Antiprotozoarios/biosíntesis , Leishmania braziliensis/inmunología , Leishmania guyanensis/inmunología , Leishmaniasis Cutánea/inmunología , Leishmaniasis Cutánea/parasitología , Adolescente , Adulto , Animales , Anticuerpos Antiprotozoarios/sangre , Antígenos de Protozoos , Antiprotozoarios/administración & dosificación , Antiprotozoarios/uso terapéutico , Brasil , Ensayo de Inmunoadsorción Enzimática , Femenino , Técnica del Anticuerpo Fluorescente Indirecta , Humanos , Leishmaniasis Cutánea/tratamiento farmacológico , Masculino , Meglumina/administración & dosificación , Meglumina/uso terapéutico , Antimoniato de Meglumina , Compuestos Organometálicos/administración & dosificación , Compuestos Organometálicos/uso terapéutico , Pruebas Cutáneas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA